Ondine Total Revenue from 2010 to 2024

OBI Stock   7.75  0.25  3.12%   
Ondine Biomedical's Total Revenue is increasing over the years with slightly volatile fluctuation. Total Revenue is expected to dwindle to about 943.3 K. Total Revenue is the total amount of income generated by the sale of goods or services related to Ondine Biomedical's primary operations. View All Fundamentals
 
Total Revenue  
First Reported
2006-06-30
Previous Quarter
766.8 K
Current Value
865.2 K
Quarterly Volatility
195.8 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Ondine Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ondine Biomedical's main balance sheet or income statement drivers, such as Other Operating Expenses of 11.8 M, Total Operating Expenses of 11.2 M or Income Tax Expense of 89.3 K, as well as many indicators such as . Ondine financial statements analysis is a perfect complement when working with Ondine Biomedical Valuation or Volatility modules.
  
This module can also supplement various Ondine Biomedical Technical models . Check out the analysis of Ondine Biomedical Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Ondine Stock

Ondine Biomedical financial ratios help investors to determine whether Ondine Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ondine with respect to the benefits of owning Ondine Biomedical security.